Fatigue News and Research

RSS

FDA approves Corindus CorPath 200 System for pivotal trial to evaluate safety, effectiveness

Corindus Vascular Robotics, a leading developer of precision vascular robotics, today announced it has been granted Food and Drug Administration conditional Investigational Device Exemption approval to evaluate the safety and effectiveness of its CorPath® 200 System in delivering and manipulating coronary guidewires and stent/balloon systems in percutaneous coronary interventions procedures.

27 Jan 2011

Chiropractic treatment helps female Army Brigadier General to battle against fibromyalgia

After 27 years of service, decorated U.S. Army Brigadier General Becky Halstead (Retired), the first female West Point graduate in U.S. history to command at the strategic level in Iraq and Afghanistan, decided to retire after being diagnosed with fibromyalgia - a medically unexplained syndrome affecting the muscles and connective tissues.

25 Jan 2011

Methodist DeBakey Heart & Vascular Center chosen for critical percutaneous heart valve study

The Methodist DeBakey Heart & Vascular Center was chosen today as a site for a critical percutaneous heart valve study. As part of the research study, Methodist physicians will replace diseased cardiac valves through a single, tiny puncture hole in the research subject's groin.

24 Jan 2011

Mathematical models to predict fatigue could reduce risk of accidents

Washington State University sleep researchers have determined that the air traffic controller in the crash of a Lexington, Ky., commuter flight was substantially fatigued when he failed to detect that the plane was on the wrong runway and cleared it for takeoff.

24 Jan 2011

PGxHealth receives FDA approval for Viibryd tablets to treat major depressive disorder

The U.S. Food and Drug Administration today approved Viibryd tablets (vilazodone hydrochloride) to treat major depressive disorder in adults.

24 Jan 2011

Semen allergy to one's own

According to a study from Dutch researchers, some men are allergic to their own semen, developing a mysterious flu-like illness after they have an ejaculation. The condition, known as post-orgasmic illness syndrome or POIS, has been documented since 2002. It manifests as feverishness, runny nose, extreme fatigue and burning eyes, which can last for up to a week.

20 Jan 2011

Ridaforolimus achieves primary endpoint in Phase 3 trial for metastatic soft-tissue and bone sarcomas

ARIAD Pharmaceuticals, Inc., today announced top-line data showing that ridaforolimus, an investigational oral mTOR inhibitor, met the primary endpoint of improved progression-free survival (PFS) compared to placebo in the Phase 3 SUCCEED trial conducted in patients with metastatic soft-tissue or bone sarcomas who previously had a favorable response to chemotherapy.

19 Jan 2011

BHI, NHLBI and AHA join to promote American Heart Month and National Wear Red Day

The Better Hearing Institute (BHI) announced today that it is joining with the National Heart, Lung, and Blood Institute (NHLBI) and the American Heart Association (AHA) to promote American Heart Month in February and to celebrate National Wear Red Day® on February 4, 2011.

19 Jan 2011

Study shows physical activity helps people with osteoarthritis to walk faster

When a traffic light at a busy intersection flashes the WALK sign, people with knee osteoarthritis worry they can't walk fast enough to make it across the street in time. New Northwestern Medicine research shows people with this common arthritis are more likely to walk fast enough if they lead physically active lives.

19 Jan 2011

RG7204 Phase III study shows significant survival benefit in patients with metastatic melanoma

Genentech, a member of the Roche Group, today announced that BRIM3, a Phase III clinical study of RG7204, met its co-primary endpoints showing a significant survival benefit in people with previously untreated BRAF V600 mutation-positive metastatic melanoma.

19 Jan 2011

More studies needed to evaluate harm or benefit of mechanical CPR

Pushing on the chest to simulate the heart's rhythmic pumping action is an essential part of cardiopulmonary resuscitation after cardiac arrest. In recent decades, manufacturers have developed several mechanical devices that claim to perform CPR more effectively than human efforts alone.

19 Jan 2011

Heart failure patients admitted to general wards fare poorly: Study

The latest research shows that patients with heart failure are twice as likely to die if they are admitted to a general hospital ward rather than one specializing in cardiology. Heart failure kills nearly a quarter of a million people in England and Wales every year and about 900,000 people in the UK have the condition that means the heart is weakened and cannot pump blood efficiently. Symptoms include fatigue, breathlessness and swollen ankles, and it can lead to premature death.

18 Jan 2011

New study finds nurses' work schedule can impact patient outcomes

A new study has found that patient deaths from pneumonia and acute myocardial infarction were significantly more likely in hospitals where nurses reported schedules with long work hours.

18 Jan 2011

Addition of caffeine to alcohol does not improve sustained attention or reaction times

Marketing efforts that encourage mixing caffeinated "energy" drinks with alcohol often try to sway young people to believe that caffeine will offset the sedating effects of alcohol and increase alertness and stamina.

13 Jan 2011

Lightning Process training course tops in survey by ME/ CFS

A revolutionary self training course has emerged top in a survey conducted by the Sussex and Kent ME/ CFS Society.

12 Jan 2011

Shionogi brings KAPVAY ADHD drug to the U.S market

Shionogi Inc., the U.S.-based group company of Shionogi & Co., Ltd., today announced a true milestone as it marks the first commercial availability for the non-central nervous system stimulant medication KAPVAY™, an extended-release oral formulation of clonidine for Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents.

10 Jan 2011

Fatigue News and Research

FDA approves Corindus CorPath 200 System for pivotal trial to evaluate safety, effectiveness

Chiropractic treatment helps female Army Brigadier General to battle against fibromyalgia

Methodist DeBakey Heart & Vascular Center chosen for critical percutaneous heart valve study

Mathematical models to predict fatigue could reduce risk of accidents

PGxHealth receives FDA approval for Viibryd tablets to treat major depressive disorder

Semen allergy to one's own

Ridaforolimus achieves primary endpoint in Phase 3 trial for metastatic soft-tissue and bone sarcomas

BHI, NHLBI and AHA join to promote American Heart Month and National Wear Red Day

Study shows physical activity helps people with osteoarthritis to walk faster

RG7204 Phase III study shows significant survival benefit in patients with metastatic melanoma

More studies needed to evaluate harm or benefit of mechanical CPR

Heart failure patients admitted to general wards fare poorly: Study

New study finds nurses' work schedule can impact patient outcomes

Addition of caffeine to alcohol does not improve sustained attention or reaction times

Lightning Process training course tops in survey by ME/ CFS

Shionogi brings KAPVAY ADHD drug to the U.S market

Quality of life measures most useful for clinical decision-making in trials with QOL as primary outcome

Tips for surviving a bout with 'stomach flu'

Pharmasset reports positive data from PSI-7977 and PSI-938 HCV clinical programs

Choosing between EGFR therapeutic options in metastatic colorectal cancer

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News